SCTB41
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SCTB41, covering 2025-01-16 to 2025-01-16. Get the full timeline:
Most recent: Clinical Trial Update: Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB41 in Adult Patients with Advanced Malignant Solid Tumours. [Phase 1, Phase 2]